Stock 2796 PHARMARISE HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Pharmarise Holdings Corporation

Equities

2796

JP3802320006

Delayed Japan Exchange
Other stock markets
 04:34:28 15/05/2024 BST 		5-day change 1st Jan Change
657 JPY 0.00% Intraday chart for Pharmarise Holdings Corporation 0.00% -0.45%
04-11 Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A MT
04-10 Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise
Pharmarise Holdings Corporation authorizes a Buyback Plan.
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023
Pharmarise's Fiscal Q1 Attributable Profit Soars 75%
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2796 Stock
  4. News Pharmarise Holdings Corporation
  5. Other languages